Avidity Biosciences

MA BD deal handshake cooperation collaboration business deal
Pharma

2025's top biopharma M&A deals

Looming patent expirations and a thawing of the biotech investment scene prompted drug developers of all stripes to pull out their checkbooks in 2025.
rare diseases

Arrowhead, Zevra fire up campaigns for Rare Disease Day 2025

Feb 28, 2025 10:18am
Influential scientists

Most influential people in biopharma—the scientists

May 9, 2022 3:00am